Genmab · 7 hours ago
VP, Sales & Marketing (Head & Neck Cancer Lead)
Princeton
Full-time
Hybrid
Director/Executive
$258K/yr - $386K/yr
15+ years expGenmab is dedicated to developing innovative antibody products for cancer treatment. The Vice President of Sales and Marketing for Head & Neck Cancer will lead the launch and lifecycle management of a new commercial product, driving strategic engagement and overseeing a talented team to ensure brand success in the US market.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Craft and communicate a compelling long-term brand vision
Lead a large cross functional team in strategic and tactical planning, ensuring alignment with global objectives and Genmab’s ambitious goals for its first fully integrated medicine in the Head & Neck cancer space
Shape and influence global strategy, leveraging insights from the US Market, the first to launch and largest market
Key contributor to the overall US commercialization portfolio strategy as a key member of the Sales & Marketing Leadership team and drive Genmab’s US success with an enterprise growth mindset
Inspire and guide a team of sales and marketing professionals, fostering a culture of excellence, collaboration, and accountability
Oversee home office and a field-based thought leader engagement team responsible for establishing and strengthening connectivity with key opinion leaders and accounts
Build internal capability through training, best‑practice sharing, and engagement
Foster a culture of commercial excellence, accountability, and continuous improvement
Role model One Genmab approach and actively drive employee engagement through strengthening the Genmab extra[not]ordinary culture
Own the P&L management responsibilities and oversight of the therapeutic portfolio/brand, accountable to senior management
Develop and oversee marketing strategies, product positioning, and branding initiatives for the US launch, and shaping global brand as the US is the lead market
Engage senior leadership on brand strategy and performance, and craft content for the Board of Directors and Investor Relations
Build, lead and mentor a high-performing account manager sales team and maximize performance & impact by building a culture of executional excellence supported by clear direction and an integrated cross-functional planning approach
Ensure alignment of thought leader strategies with enterprise priorities
Participate in engagements with the most influential global, regional, or national thought leaders
Work closely with departments such as Market Access, Medical Affairs, Business Operations and Regulatory to optimize launch strategies and tactics
Key partner with the Therapeutic Area Sales and Marketing leaders and their respective teams
Ensure seamless integration of insights and strategies across functions
Partner with R&D including the Compound Development Team to shape and influence key brand and portfolio decisions within the Therapeutic Area
Monitor market dynamics, competitive landscape, and emerging trends
Use insights to adapt strategies and identify growth opportunities
Engage with internal and external stakeholders, including partners, to develop and execute market insights and business strategies
Responsible for being the company representative in key external engagements
Lead US Market commercial insights, shaping key development decisions for the therapeutic area portfolio
Lifecycle management in emerging areas outside of the therapeutic area are out of scope and will be managed by the VP, US Sales & Marketing
Influence brand strategy from early development through its lifecycle for Genmab’s first wholly integrated medicine
Ensure strategic plan and readiness which accounts for initial and planned additional indications
Qualification
Required
Bachelor's Degree from an accredited institution is required; advanced degree preferred
15+ years in the pharmaceutical industry, with significant experience in commercial roles at the enterprise leadership level Oncology experience is required, with launch experience in Solid Tumors required and in Head & Neck cancer highly preferred
People leadership experience within pharmaceutical commercial business, leading high-performing sales and marketing teams to demonstrated success is required
Strong ability to analyze market trends, develop strategic insights, and execute effective brand plans
Proven experience translating brand strategy into integrated campaign plans leveraging technology and able to demonstrate driving innovation
Outstanding communication and presentation skills, with the ability to convey complex concepts and strategies clearly
Thrive in fast-paced, ambiguous environments, demonstrating an entrepreneurial mindset and a proactive, decisive approach
Benefits
401(k) Plan: 100% match on the first 6% of contributions
Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance
Voluntary Plans: Critical illness, accident, and hospital indemnity insurance
Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave
Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support
Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses
Company
Genmab
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
1001-5000 employees
H1B Sponsorship
Genmab has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (10)
2023 (6)
2022 (3)
2021 (3)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$11.7BKey Investors
Morgan Stanley Senior FundingGlaxoSmithKlineIndex Ventures
2025-11-18Post Ipo Debt· $6B
2025-09-29Post Ipo Debt· $5.5B
2010-07-01Post Ipo Equity· $134M
Leadership Team
Anthony Pagano
Chief Financial Officer
Anthony Mancini
EVP & Chief Operating Officer
Recent News
2026-01-20
2026-01-19
2026-01-19
Company data provided by crunchbase